Antidepressant drugs, convulsions and epilepsy.
Journal: 1983/April - British Journal of Clinical Pharmacology
ISSN: 0306-5251
PUBMED: 6824560
Abstract:
1 Evidence concerning the convulsant effects of non-monoamine oxidase inhibitor antidepressant drugs has been reviewed. 2 Mianserin is convulsant in therapeutic doses but seizures have not been reported following overdose. 3 The convulsant effects of mianserin are probably no greater than for other non-monoamine oxidase inhibitor antidepressant drugs. 4 Enzyme-inducing anti-epileptic drugs can reduce the peak plasma concentration of mianserin and shorten its elimination half-life, probably by inducing its metabolism.
Relations:
Content
Citations
(2)
References
(18)
Diseases
(1)
Conditions
(1)
Chemicals
(1)
Organisms
(1)
Processes
(2)
Similar articles
Articles by the same authors
Discussion board
Br J Clin Pharmacol 15(Suppl 2): 295S-298S

Antidepressant drugs, convulsions and epilepsy

Abstract

1 Evidence concerning the convulsant effects of non-monoamine oxidase inhibitor antidepressant drugs has been reviewed.

2 Mianserin is convulsant in therapeutic doses but seizures have not been reported following overdose.

3 The convulsant effects of mianserin are probably no greater than for other non-monoamine oxidase inhibitor antidepressant drugs.

4 Enzyme-inducing anti-epileptic drugs can reduce the peak plasma concentration of mianserin and shorten its elimination half-life, probably by inducing its metabolism.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (490K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Betts TA, Kalra PL, Cooper R, Jeavons PM. Epileptic fits as a probable side-effect of amitriptyline. Report of seven cases. Lancet. 1968 Feb 24;1(7539):390–392. [PubMed] [Google Scholar]
  • Crome P, Newman B. Poisoning with maprotiline and mianserin. Br Med J. 1977 Jul 23;2(6081):260–260.[PMC free article] [PubMed] [Google Scholar]
  • Dallos V, Heathfield K. Iatrogenic epilepsy due to antidepressant drugs. Br Med J. 1969 Oct 11;4(5675):80–82.[PMC free article] [PubMed] [Google Scholar]
  • Davison K. EEG activation after intravenous amitriptyline. Electroencephalogr Clin Neurophysiol. 1965 Sep;19(3):298–300. [PubMed] [Google Scholar]
  • Goel KM, Shanks RA. Amitriptyline and imipramine poisoning in children. Br Med J. 1974 Feb 16;1(5902):261–263.[PMC free article] [PubMed] [Google Scholar]
  • Harms HH, Gooren L, Spoelstra AJ, Hesse C, Verschoor L. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol. Br J Clin Pharmacol. 1978 Jan;5(1):19–26.[PMC free article] [PubMed] [Google Scholar]
  • KILOH LG, DAVISON K, OSSELTON JW. An electroencephalographic study of the analeptic effects of imipramine. Electroencephalogr Clin Neurophysiol. 1961 Apr;13:216–223. [PubMed] [Google Scholar]
  • Legg NJ, Swash M. Clinical note: seizures and EEG activation after trimipramine. Epilepsia. 1974 Mar;15(1):131–135. [PubMed] [Google Scholar]
  • Perucca E, Richens A. Interaction between phenytoin and imipramine. Br J Clin Pharmacol. 1977 Aug;4(4):485–486.[PMC free article] [PubMed] [Google Scholar]
  • Simeon J, Spero M, Fink M. Clinical and EEG studies of doxepin. An interim report. Psychosomatics. 1969 May-Jun;10(3):14–17. [PubMed] [Google Scholar]
  • Steel CM, O'Duffy J, Brown SS. Clinical effects and treatment of imipramine and amitriptyline poisoning in children. Br Med J. 1967 Sep 9;3(5566):663–667.[PMC free article] [PubMed] [Google Scholar]
  • STEINER WG, HIMWICH HE. EFFECTS OF ANTIDEPRESSANT DRUGS ON LIMBIC STRUCTURES OF RABBIT. J Nerv Ment Dis. 1963 Sep;137:277–284. [PubMed] [Google Scholar]
  • Toone BK, Fenton GW. Epileptic seizures induced by psychotropic drugs. Psychol Med. 1977 May;7(2):265–270. [PubMed] [Google Scholar]
  • Trimble M. Non-monoamine oxidase inhibitor antidepressants and epilepsy: a review. Epilepsia. 1978 Jun;19(3):241–250. [PubMed] [Google Scholar]
  • Trimble MR. New antidepressant drugs and the seizure threshold. Neuropharmacology. 1980 Dec;19(12):1227–1228. [PubMed] [Google Scholar]
  • Trimble M, Anlezark G, Meldrum B. Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotoninergic mechanisms. Psychopharmacology (Berl) 1977 Jan 31;51(2):159–164. [PubMed] [Google Scholar]
  • Tyrer P, Steinberg B, Watson B. Possible epileptogenic effect of mianserin. Lancet. 1979 Oct 13;2(8146):798–799. [PubMed] [Google Scholar]
  • Wallach MB, Winters WD, Mandell AJ, Spooner CE. A correlation of EEG, reticular multiple unit activity and gross behavior following various antidepressant agents in the cat. IV. Electroencephalogr Clin Neurophysiol. 1969 Dec;27(6):563–573. [PubMed] [Google Scholar]
Abstract
1 Evidence concerning the convulsant effects of non-monoamine oxidase inhibitor antidepressant drugs has been reviewed.2 Mianserin is convulsant in therapeutic doses but seizures have not been reported following overdose.3 The convulsant effects of mianserin are probably no greater than for other non-monoamine oxidase inhibitor antidepressant drugs.4 Enzyme-inducing anti-epileptic drugs can reduce the peak plasma concentration of mianserin and shorten its elimination half-life, probably by inducing its metabolism.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.